MX362994B - Preparacion farmaceutica que comprende un derivado de aminopirazol. - Google Patents

Preparacion farmaceutica que comprende un derivado de aminopirazol.

Info

Publication number
MX362994B
MX362994B MX2016000775A MX2016000775A MX362994B MX 362994 B MX362994 B MX 362994B MX 2016000775 A MX2016000775 A MX 2016000775A MX 2016000775 A MX2016000775 A MX 2016000775A MX 362994 B MX362994 B MX 362994B
Authority
MX
Mexico
Prior art keywords
pharmaceutical preparation
aminopyrazole derivative
general formula
aminopyrazole
derivative
Prior art date
Application number
MX2016000775A
Other languages
English (en)
Other versions
MX2016000775A (es
Inventor
Nihira Jun
Okazaki Kensuke
Yoshimura Shiho
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of MX2016000775A publication Critical patent/MX2016000775A/es
Publication of MX362994B publication Critical patent/MX362994B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a las formulaciones farmacéuticas de acuerdo con la presente invención que incluyen una sal de sulfato de alquilo y un compuesto representado por la fórmula general (I) posterior (en donde R1 a R4 son como se definieron en la descripción) o un tautómero del mismo, o las sales del mismo farmacéuticamente aceptable. (ver Fórmula).
MX2016000775A 2013-07-31 2014-07-31 Preparacion farmaceutica que comprende un derivado de aminopirazol. MX362994B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013159521 2013-07-31
PCT/JP2014/070154 WO2015016295A1 (ja) 2013-07-31 2014-07-31 アミノピラゾール誘導体含有医薬品製剤

Publications (2)

Publication Number Publication Date
MX2016000775A MX2016000775A (es) 2016-04-27
MX362994B true MX362994B (es) 2019-03-01

Family

ID=52431822

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000775A MX362994B (es) 2013-07-31 2014-07-31 Preparacion farmaceutica que comprende un derivado de aminopirazol.

Country Status (15)

Country Link
US (1) US9814776B2 (es)
EP (1) EP2886118B1 (es)
JP (1) JP5681940B1 (es)
KR (1) KR20160035003A (es)
CN (1) CN105636587B (es)
AU (1) AU2014297298B2 (es)
CA (1) CA2919075A1 (es)
DK (1) DK2886118T3 (es)
ES (1) ES2691559T3 (es)
HK (1) HK1220633A1 (es)
MX (1) MX362994B (es)
RU (1) RU2684618C2 (es)
TR (1) TR201815156T4 (es)
TW (1) TWI637744B (es)
WO (1) WO2015016295A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2756175T3 (es) 2013-12-27 2020-04-27 Chugai Pharmaceutical Co Ltd Genes mutantes guardián de fgfr y fármacos que se dirigen a los mismos
US10479780B2 (en) 2015-06-17 2019-11-19 Chugai Seiyaku Kabushiki Kaisha Aminopyrazole derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1147907A (en) * 1979-11-07 1983-06-14 Kenneth E. Edds Water-based ink composition
JPS5876475A (ja) 1981-10-31 1983-05-09 Kanzaki Paper Mfg Co Ltd 澱粉糊液の改質方法
GB0423554D0 (en) 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
GT200600119A (es) * 2005-03-24 2006-10-25 Composiciones farmaceuticas
ES2383273T3 (es) * 2008-07-23 2012-06-19 F. Hoffmann-La Roche Ag Compuestos heterocíclicos antivíricos
BR112012008094A2 (pt) 2009-08-07 2020-08-18 Chugai Seiyaku Kabushiki Kaisha derivado de aminopirazol, seu uso, composição farmacêutica que o compreende, agentes para inibir a atividade de fgfr e para prevenir ou tratar câncer
JP5620417B2 (ja) 2011-02-07 2014-11-05 中外製薬株式会社 アミノピラゾール誘導体を含む医薬

Also Published As

Publication number Publication date
MX2016000775A (es) 2016-04-27
TW201601720A (zh) 2016-01-16
WO2015016295A1 (ja) 2015-02-05
US20150238607A1 (en) 2015-08-27
JPWO2015016295A1 (ja) 2017-03-02
EP2886118B1 (en) 2018-09-05
TR201815156T4 (tr) 2018-11-21
US9814776B2 (en) 2017-11-14
CN105636587A (zh) 2016-06-01
RU2016106955A (ru) 2017-09-04
ES2691559T3 (es) 2018-11-27
HK1220633A1 (zh) 2017-05-12
DK2886118T3 (en) 2018-11-05
EP2886118A1 (en) 2015-06-24
TWI637744B (zh) 2018-10-11
CN105636587B (zh) 2018-05-18
JP5681940B1 (ja) 2015-03-11
RU2684618C2 (ru) 2019-04-10
KR20160035003A (ko) 2016-03-30
EP2886118A4 (en) 2016-01-27
AU2014297298B2 (en) 2019-10-17
CA2919075A1 (en) 2015-02-05
AU2014297298A1 (en) 2015-12-24
RU2016106955A3 (es) 2018-05-25

Similar Documents

Publication Publication Date Title
PH12016502398A1 (en) Dihydropyrimido loop derivative as hbv inhibitor
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
MX2016006336A (es) Compuestos pirazolopirimidina.
MX2019009100A (es) Nuevos derivados de triazolo[4,5-d]pirimidina.
PH12015501843A1 (en) Novel pyrazol derivatives
MD20140072A2 (ro) Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
IN2014MN02598A (es)
PH12015501933B1 (en) Novel pyridine derivatives
PH12015502118A1 (en) Pyridin-4-yl derivatives
MY186547A (en) 4?-fluoro-2?-methyl substituted nucleoside derivatives
PH12015502471A1 (en) Purine derivatives as cb2 receptor agonists
PH12015502409B1 (en) Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists
PH12015501146A1 (en) Hydantoin derivative
MX2016000775A (es) Preparacion farmaceutica que comprende un derivado de aminopirazol.
PH12015501056A1 (en) 2-pyridone compound
IN2013CH04314A (es)
IN2013MU02612A (es)
IN2013CH04519A (es)